News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Zisson Alex
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/06/2015 |
4
| Zisson Alex (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 4,835,731 shares
@ $0 |
|
| 01/30/2015 |
4
| Zisson Alex (Director) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Sold 730,000 shares
@ $53.11, valued at
$38.8M
|
|
| 01/12/2015 |
4
| Zisson Alex (Director) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 24,008 shares
@ $51.574, valued at
$1.2M
Exercised 59,277 warrants
@ $3.879, valued at
$229.9k
Exercised 169,630 warrants
@ $3.879, valued at
$658k
Exercised 90,228 warrants
@ $3.879, valued at
$350k
|
|
| 10/14/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/19/2014 |
4/A
| Zisson Alex (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 12,400 shares
@ $20.598, valued at
$255.4k
Exercised 65,839 warrants
@ $3.879, valued at
$255.4k
|
|
| 09/09/2014 |
4
| Zisson Alex (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Sold 12,400 shares
@ $20.598, valued at
$255.4k
Exercised (in-or-at-the-money) 65,839 warrants
@ $3.879, valued at
$255.4k
|
|
| 02/12/2014 |
4
| Zisson Alex (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Converted 5,083,451 shares
@ $0
Bought 83,334 shares
@ $12, valued at
$1M
Converted 2,289,771 convertible preferred
@ $0
Converted 7,552,207 convertible preferred
@ $0
Converted 11,915,254 convertible preferred
@ $0
Converted 1,118,298 convertible preferred
@ $0
Converted 296,281 options to buy
@ $0.862, valued at
$255.4k
Converted 65,839 warrants
@ $3.879, valued at
$255.4k
Converted 270,687 options to buy
@ $0.862, valued at
$233.3k
Converted 60,151 warrants
@ $3.879, valued at
$233.3k
Converted 266,750 options to buy
@ $0.862, valued at
$229.9k
|
|
| 07/17/2013 |
4/A
| THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Acquired 1,675,677 shares
@ $6, valued at
$10.1M
Acquired 762,892 shares
@ $6, valued at
$4.6M
Granted 25,000 options to buy
@ $4, valued at
$100k
Granted 31,835 options to buy
@ $4.24, valued at
$135k
Granted 100,000 options to buy
@ $0.11, valued at
$11k
Granted 25,000 options to buy
@ $0.22, valued at
$5.5k
Granted 25,000 options to buy
@ $0.22, valued at
$5.5k
Granted 161,855 warrants
@ $0.08, valued at
$12.9k
Granted 161,855 warrants
@ $0.08, valued at
$12.9k
|
|
| 07/17/2013 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 06/04/2013 |
4
| Zisson Alex (Director) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Granted 28,000 options to buy
@ $3.116, valued at
$87.2k
|
|
| 01/14/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 08/09/2012 |
4
| Zisson Alex (Director) has filed a Form 4 on TRANZYME INC|
Txns:
| Granted 31,835 options to buy
@ $4.24, valued at
$135k
|
|
| 04/21/2011 |
4
| Zisson Alex (Director) has filed a Form 4 on TRANZYME INC|
Txns:
| Granted 25,000 options to buy
@ $4, valued at
$100k
|
|
| 04/06/2011 |
4
| THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on TRANZYME INC|
Txns:
| Converted 2,103,623 shares
@ $0
Converted 78,175 shares
@ $0
Converted 7,988 shares
@ $0
Bought 794,966 shares
@ $4, valued at
$3.2M
Bought 14,568 shares
@ $4, valued at
$58.3k
Bought 2,966 shares
@ $4, valued at
$11.9k
Converted 14,725,374 convertible preferred
@ $0
Converted 547,229 convertible preferred
@ $0
Converted 55,946 convertible preferred
@ $0 |
|
|
|